EUVIMEDEUVIMED entdecken
MetaanalyseSystematische Übersicht

Association Between Metabolic Syndrome and the Risk of Lung Cancer: A Meta-Analysis

Zhao Zhang, Qinxiang Liu, Congcong Huang, Jun Wu, Yingsheng Wen

Hormone and Metabolic Research · 01.12.2023 · 55 (12) · 846-854

DOI: 10.1055/a-2179-0809 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.12.2023. Verfasst von Zhao Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Oncology, Hainan Cancer Hospital, The Affiliated Cancer Hospital of Hainan Medical University, Haikou City, Hainan Province, Chi…. Hauptthemen laut MEDLINE: Metabolic Syndrome, Lung Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Previous studies showed conflicting results regarding the association between metabolic syndrome (MetS) and risk of lung cancer. We performed a systemic review and meta-analysis to determine the relationship between MetS and lung cancer incidence and mortality in adults. Longitudinal follow-up studies were identified by search of Medline, Embase, Cochrane Library, and Web of Science. By incorporating potential heterogeneity into the model, a randomized-effects model was selected to pool the results. Fourteen observational studies were included. Pooled results showed that MetS was associated with a higher risk of lung cancer incidence [risk ratio (RR): 1.15, 95% confidence interval (CI): 1.05 to 1.26, p=0.002; I2=89%). Subgroup analysis suggested that the association was not significantly affected by study country, design, sex of the participants, adjustment of smoking, or different study quality scores (p for subgroup difference all>0.05). The association was predominantly contributed by studies with MetS defined by the National Cholesterol Education Program Adult Treatment Panel-III rather than those with MetS defined by the International Diabetes Foundation criteria, and the association seemed to be stronger in studies with follow-up within 6 years than those over 6 years (p for subgroup difference=0.03 and 0.04, respectively). In addition, pooled results also showed that MetS was associated with a higher risk of lung cancer mortality (RR: 1.46, 95% CI: 1.19 to 1.79, p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metabolic SyndromeLung NeoplasmsAdultHumansRisk FactorsIncidenceOdds Ratio

Autor:innen und Institutionen

  • Department of Breast Oncology, Hainan Cancer Hospital, The Affiliated Cancer Hospital of Hainan Medical University, Haikou City, Hainan Province, China.
  • Department of Medical Oncology, Hainan Cancer Hospital, The Affiliated Cancer Hospital of Hainan Medical University, Haikou City, Hainan Province, China.
  • Department of Thoracic Surgery, Hainan Cancer Hospital, The Affiliated Cancer Hospital of Hainan Medical University, Haikou City, Hainan Province, China.
  • Department of Thoracic Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.

Zitieren

APA

Zhang, Z., Liu, Q., Huang, C., Wu, J., & Wen, Y. (2023). Association Between Metabolic Syndrome and the Risk of Lung Cancer: A Meta-Analysis. Hormone and Metabolic Research, 55(12), 846-854. https://doi.org/10.1055/a-2179-0809

Vancouver

Zhang Z, Liu Q, Huang C, Wu J, Wen Y. Association Between Metabolic Syndrome and the Risk of Lung Cancer: A Meta-Analysis. Hormone and Metabolic Research. 2023;55(12):846-854. doi:10.1055/a-2179-0809

BibTeX
@article{Zhang2023,
  author = {Zhang, Zhao and Liu, Qinxiang and Huang, Congcong and Wu, Jun and Wen, Yingsheng},
  title = {Association Between Metabolic Syndrome and the Risk of Lung Cancer: A Meta-Analysis},
  journal = {Hormone and Metabolic Research},
  year = {2023},
  volume = {55},
  number = {12},
  pages = {846--854},
  doi = {10.1055/a-2179-0809}
}
Kostenlos starten →